Market Overview

R.F. Lafferty Devalues Auxilium, QLT Deal

Related AUXL
US Stock Futures Rise; Jobless Claims Report In Focus
UPDATE: Auxilium Pharma Reports Wider-Than-Expected Q2 Loss

R.F. Lafferty graded Auxilium Pharmaceuticals' (NASDAQ: AUXL) acquisition of QLT (NASDAQ: QLT) to be neutral, based on lack of sufficient cash for Auxilium to complete the deal.

Auxilium announced on Thursday that it will acquire QLT for 3.1359 shares of Auxilium stock, equivalent to a 25 percent premium based on QLT's stock price on June 25, 2014. The merger is expected to close later in the fourth quarter of 2014.
Despite the deal announced to be a stock-for-stock deal, Auxilium lacking the cash power could mean that acquiring QLT creates an opportunity cost, making the deal less valuable.

Shares of Auxilium dropped 3.93 percent to $20.43 in the middle of Thursday's market hours. Shares have rebounded in Friday's action, up less than one percent to $20.76.

Posted-In: R.F. LaffertyAnalyst Color Analyst Ratings

 

Most Popular

Related Articles (AUXL + QLT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters